You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
In vitro and in vivo evaluation of elephant p53 (EP53) protein nanoparticles for pediatric osteosarcoma
SBC: Peel Therapeutics, Inc Topic: 102PROJECT SUMMARY ABSTRACT PEEL TherapeuticsIncis a life sciences company created to impact the lives of people with cancerBased on the research efforts of DrJoshua Schiffman and DrAvi SchroederPEEL TherapeuticsPEELhas created liposomal nanoparticles that have been loaded with elephant pEPproteins as a new class of anti cancer protein therapeuticsElephants have an unexpectedly low rate of cancer giv ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Astroglial EAAT2 Changes in Live TBI Brain Determined by PET Imaging
SBC: RIO PHARMACEUTICALS, INC. Topic: NINDSPROJECT SUMMARYTraumatic Brain InjuryTBIis one of the most significant Public Health trauma diseases of our timeDiagnoses of various TBI forms rely on patient self reportingestablished clinical rating scalesand multimodality imaging to an extentTBI elicits complexheterogeneous pathological eventsincluding mechanical injuryhemorrhageand progressive secondary processes such as central and peripheral ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Microfluidic diamond NMR sensor
SBC: ODMR Technologies, Inc Topic: 400Project SummaryNuclear magnetic resonanceNMRis amongst the most powerful analytical techniques ever inventedas recognized byNobel Prizes for methods development aloneNonethelessNMR is notoriously plagued by poor sensitivity and spatial resolutionState of the art NMR spectrometers typically feature detection thresholds ofnanograms forL sample volumesThis places NMR sensitivity many orders of magnit ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Sonomyographic Control of Fiber-Optically Sensorized Prosthetic Fingers for Graded Force Actuation
SBC: INTELLIGENT FIBER OPTIC SYSTEMS CORP Topic: NINDSSonomyographic Control of Fiber Optically Sensorized Prosthetic Fingers for Graded Force Actuation Intelligent Fiber Optic Systems CorporationIFOSCalle del MundoSanta ClaraCAwww ifos com PROJECT SUMMARY ABSTRACTMAXIMUMLINESIn this Phase I SBIR applicationIFOS and George Mason UniversityGMUpropose an innovative control system leveraging on two emerging technologiesultrasonic imaging based readout o ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
The Microscopic Imaging of Epigenetic Landscape- NeuroDevelopment (MIEL-ND) assay: a high throughput platform to screen compounds for neurodevelopmental effects
SBC: VALA SCIENCES, INC. Topic: 101Neurodevelopmental diseasesNDDsAutism Spectrum DisorderASDIntellectual DisabilitiesBipolar disordersand Schizophreniaetcare prevalent and due to errors in neurodifferentiation and neurocircuitryWhile NDDsin many casesare due to inherited mutationsevidence is mounting that prenatal exposure to environmental toxicants also cause NDDs via disruption of epigeneticse gmodifications of histoneshistone t ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Hybrid DNN-based Transfer Learning and CNN-based Supervised Learning for Object Recognition in Multi-modal Infrared Imagery
SBC: TOYON RESEARCH CORPORATION Topic: 1On this effort Toyon Research Corp. and The Pennsylvania State University are developing deep learning-based algorithms for object recognition and new class discovery in look-down infrared (IR) imagery. Our approach involves the development of a hybrid classifier that exploits both transfer learning and semi-supervised paradigms in order to maintain good generalization accuracy, especially when li ...
STTR Phase I 2018 Department of DefenseNational Geospatial-Intelligence Agency -
Therapeutic Inhibition of BCL6 in Systemic Lupus Erythematosus
SBC: L2 Diagnostics, LLC Topic: NIAMSABSTRACT Systemic autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are characterized by polyclonal T cell activation driving the production of pathogenic class switched autoantibodiesThe class switchedsomatically mutated antibodies are generated from germinal centerGCB cellsA subset of effector CDT cellsknown as T follicular helperTfhcellshas been shown to play an ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
An innovative WGS platform for discovery, annotation, and interpretation of all forms of human genetic variation.
SBC: Base2 Genomics LLC Topic: 172PROJECT SUMMARY Modern DNA sequencing technologies have transformed our ability to interrogate human genomes in a single experimentthereby eliminating the inherent blind spots of gene panels and whole exome sequencingFurthermorerecent speed and economy improvements are driving the cost of whole genome sequencingWGSdown to that of WESthereforewe foresee a transition over the next two years to WGS a ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Portable Liquid Chromatograph for Point-of-Care Monitoring of Illicit Substances
SBC: AXCEND LLC Topic: R41Project Summary Abstract Point of carePOCtesting of clinical samples for the presence of illegal substances and their metabolites is important for monitoring substance use disordersemployment screeningand legal matters relating to drug abstinenceTypical immunoassay screening methods suffer from higher false testing rates and do not provide quantitative informationConfirmatory tests that are used f ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Point of care detection of extracellular vesicles in urine for diagnosis of preeclampsia
SBC: Sersense Inc Topic: NICHDPreeclampsiaPEis a pregnancy specific disorder characterized by hypertension and commonly by the appearance of urinary proteinThis disorder occurs inof pregnancies worldwide and is the second leading cause of maternal fetal morbidity and mortality worldwideIn low resource settingsPE accounts for up toof maternal deathsThe etiology of this disease is poorly understoodThis confounds therapeutic inte ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health